Skip to main content

Air Pollution From Fossil Fuels Tied to 5 Million Excess Deaths Annually

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 30, 2023.

By Lori Solomon HealthDay Reporter

THURSDAY, Nov. 30, 2023 -- Phasing out fossil fuels might have a greater impact on global deaths than previously thought, according to a study published online Nov. 29 in The BMJ.

Jos Lelieveld, Ph.D., from the Max Planck Institute for Chemistry in Mainz, Germany, and colleagues estimated all-cause and cause-specific deaths attributable to fossil fuel-related air pollution. The analysis included data from the Global Burden of Disease 2019 study and observational fine particulate matter and population data from the National Aeronautics and Space Administration.

The researchers estimated that globally, there are 8.34 million all-cause excess deaths per year due to fine particulate and ozone air pollution. Most of this mortality burden is tied to cardiometabolic conditions (52 percent), including ischemic heart disease (30 percent) and stroke and chronic obstructive pulmonary disease (16 percent for each). Globally, an estimated 5.13 million excess deaths annually are attributable to ambient air pollution from fossil fuel use and therefore could potentially be avoided by phasing out fossil fuels (~82 percent of the maximum number of air pollution deaths). Rather than a complete phase-out, smaller reductions indicate that responses are not strongly nonlinear.

"Phasing out fossil fuels is deemed to be an effective intervention to improve health and save lives as part the United Nations' goal of climate neutrality by 2050," the authors write.

Abstract/Full Text

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Semaglutide Boosts Kidney Outcomes With Obesity + Cardiovascular Disease

TUESDAY, May 28, 2024 -- Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease...

Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older

TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.